APA (7th ed.) Citation

Saito, Y., Konno, K., Sato, M., Nakano, M., Kato, Y., Saito, H., & Serizawa, H. (2019). Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori. Cancers, 11(1), 116. https://doi.org/10.3390/cancers11010116

Chicago Style (17th ed.) Citation

Saito, Yoshimasa, Kaho Konno, Moeka Sato, Masaru Nakano, Yukako Kato, Hidetsugu Saito, and Hiroshi Serizawa. "Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate Against Sitafloxacin-Resistant Helicobacter Pylori." Cancers 11, no. 1 (2019): 116. https://doi.org/10.3390/cancers11010116.

MLA (9th ed.) Citation

Saito, Yoshimasa, et al. "Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate Against Sitafloxacin-Resistant Helicobacter Pylori." Cancers, vol. 11, no. 1, 2019, p. 116, https://doi.org/10.3390/cancers11010116.